Sanova Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 2.40 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.40 Cr
as on 15-12-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 3.00 Cr
as on 15-12-2024
- Revenue 0.85%
(FY 2018)
- Profit 229.78%
(FY 2018)
- Ebitda 26.30%
(FY 2018)
- Net Worth 3.82%
(FY 2018)
- Total Assets -16.39%
(FY 2018)
About Sanova Pharma Chem
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 2.40 Cr and a paid-up capital of Rs 1.40 Cr.
The company currently has active open charges totaling ₹3.00 Cr.
Giridhara Pulleti, Anjaiah Kadari, and Parijatha Kadari serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC052453
- Company No.
052453
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2007
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Social Media
What products or services does Sanova Pharma Chem Private Limited offer?
Sanova Pharma Chem Private Limited offers a wide range of products and services, including Insecticides, Agricultural Pesticides.
Who are the key members and board of directors at Sanova Pharma Chem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Giridhara Pulleti  | Director | 22-Jan-2007 | Current |
| Anjaiah Kadari | Director | 10-Nov-2018 | Current |
| Parijatha Kadari | Director | 10-Nov-2018 | Current |
Financial Performance of Sanova Pharma Chem.
Sanova Pharma Chem Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 0.85% increase. The company also saw a substantial improvement in profitability, with a 229.78% increase in profit. The company's net worth moved up by a moderate rise of 3.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanova Pharma Chem?
In 2018, Sanova Pharma Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Apsara Mining & Contractors India Private LimitedActive 11 years 1 month
Anjaiah Kadari and Parijatha Kadari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 21 Jul 2009 | ₹3.00 Cr | Open |
How Many Employees Work at Sanova Pharma Chem?
Sanova Pharma Chem has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanova Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanova Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
